[{"address1": "11 Great Valley Parkway", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "484 328 4701", "website": "https://www.ocugen.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is involved in the development of OCU200, a novel fusion protein for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.", "fullTimeEmployees": 95, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shankar  Musunuri M.B.A., Ph.D.", "age": 59, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 1151298, "exercisedValue": 0, "unexercisedValue": 347968}, {"maxAge": 1, "name": "Dr. Uday B. Kompella Ph.D.", "age": 57, "title": "Co-founder & Independent Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 61875, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Arun  Upadhyay Ph.D.", "age": 42, "title": "Chief Scientific Officer and Head of Research & Development", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 649630, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Huma  Qamar CMI, M.D., M.P.H.", "age": 39, "title": "Chief Medical Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 602737, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "John  Kouch J.D.", "title": "General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tiffany J. Hamilton M.B.A.", "title": "AVP & Head of Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristen  Craft", "title": "Head of People & Culture", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Shine M.B.A.", "title": "Senior Vice President of Commercial", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jyothy  Pillai M.S.", "title": "VP & Head of Regulatory & Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Durgaprasad  Annavajjula Ph.D.", "title": "VP, Head of Program Management & Chief of Staff", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 9, "overallRisk": 10, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.6621, "open": 0.67, "dayLow": 0.66, "dayHigh": 0.7038, "regularMarketPreviousClose": 0.6621, "regularMarketOpen": 0.67, "regularMarketDayLow": 0.66, "regularMarketDayHigh": 0.7038, "payoutRatio": 0.0, "beta": 4.23, "forwardPE": -2.679231, "volume": 1976091, "regularMarketVolume": 1976091, "averageVolume": 3800657, "averageVolume10days": 2853710, "averageDailyVolume10Day": 2853710, "bid": 0.696, "ask": 0.7999, "bidSize": 1, "askSize": 1, "marketCap": 203416976, "fiftyTwoWeekLow": 0.515, "fiftyTwoWeekHigh": 2.06, "priceToSalesTrailing12Months": 50.164482, "fiftyDayAverage": 0.65536, "twoHundredDayAverage": 0.90614, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 167331776, "profitMargins": 0.0, "floatShares": 287374360, "sharesOutstanding": 292014016, "sharesShort": 68666964, "sharesShortPriorMonth": 67513578, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.2351, "heldPercentInsiders": 0.01598, "heldPercentInstitutions": 0.24558, "shortRatio": 16.08, "shortPercentOfFloat": 0.2391, "impliedSharesOutstanding": 292014016, "bookValue": 0.102, "priceToBook": 6.829412, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -54054000, "trailingEps": -0.2, "forwardEps": -0.26, "lastSplitFactor": "1:60", "lastSplitDate": 1569801600, "enterpriseToRevenue": 41.266, "enterpriseToEbitda": -3.17, "52WeekChange": -0.6035928, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 0.6966, "targetHighPrice": 8.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.75, "targetMedianPrice": 7.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 58514000, "totalCashPerShare": 0.2, "ebitda": -52789000, "totalDebt": 32503000, "quickRatio": 2.71, "currentRatio": 2.857, "totalRevenue": 4055000, "debtToEquity": 109.689, "revenuePerShare": 0.015, "returnOnAssets": -0.46566, "returnOnEquity": -1.5400901, "grossProfits": -28071000, "freeCashflow": -24644124, "operatingCashflow": -42142000, "revenueGrowth": -0.458, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -18.11518, "financialCurrency": "USD", "symbol": "OCGN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Ocugen, Inc.", "longName": "Ocugen, Inc.", "regularMarketChangePercent": 5.2036204, "regularMarketPrice": 0.6966, "corporateActions": [], "regularMarketTime": 1746723928, "exchange": "NCM", "messageBoardId": "finmb_303874231", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketDayRange": "0.66 - 0.7038", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 3800657, "fiftyTwoWeekLowChange": 0.18160003, "fiftyTwoWeekLowChangePercent": 0.35262144, "fiftyTwoWeekRange": "0.515 - 2.06", "fiftyTwoWeekHighChange": -1.3634, "fiftyTwoWeekHighChangePercent": -0.6618447, "fiftyTwoWeekChangePercent": -60.35928, "dividendDate": 1569801600, "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1417617000000, "regularMarketChange": 0.034500003, "earningsTimestamp": 1746793800, "earningsTimestampStart": 1746793800, "earningsTimestampEnd": 1746793800, "earningsCallTimestampStart": 1746793800, "earningsCallTimestampEnd": 1746793800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.2, "epsForward": -0.26, "epsCurrentYear": -0.26, "priceEpsCurrentYear": -2.679231, "cryptoTradeable": false, "fiftyDayAverageChange": 0.041240036, "fiftyDayAverageChangePercent": 0.062927306, "twoHundredDayAverageChange": -0.20954001, "twoHundredDayAverageChangePercent": -0.23124462, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "displayName": "Ocugen", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]